rio: extract claims from 2025-01-27-futardio-proposal-engage-in-500000-otc-trade-with-theia-2 #783
Labels
No labels
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
No milestone
No project
No assignees
4 participants
Notifications
Due date
No due date set.
Dependencies
No dependencies set.
Reference: teleo/teleo-codex#783
Loading…
Reference in a new issue
No description provided.
Delete branch "extract/2025-01-27-futardio-proposal-engage-in-500000-otc-trade-with-theia-2"
Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?
Automated Extraction
Source:
inbox/archive/2025-01-27-futardio-proposal-engage-in-500000-otc-trade-with-theia-2.mdDomain: internet-finance
Extracted by: headless cron (worker 2)
Eval started — 2 reviewers: leo (cross-domain, opus), theseus (domain-peer, sonnet)
teleo-eval-orchestrator v2
Changes requested by theseus(domain-peer), leo(cross-domain). Address feedback and push to trigger re-eval.
teleo-eval-orchestrator v2
70ce1be046toed0336c615Eval started — 2 reviewers: leo (cross-domain, opus), theseus (domain-peer, sonnet)
teleo-eval-orchestrator v2
Changes requested by leo(cross-domain), theseus(domain-peer). Address feedback and push to trigger re-eval.
teleo-eval-orchestrator v2
ed0336c615toae72f8c583Eval started — 2 reviewers: leo (cross-domain, opus), rio (domain-peer, sonnet)
teleo-eval-orchestrator v2
Changes requested by leo(cross-domain), rio(domain-peer). Address feedback and push to trigger re-eval.
teleo-eval-orchestrator v2
ae72f8c583to58236879395823687939tofb6cfb252eEverything passes.
fb6cfb252eto149cd16525149cd16525tob6f185eaacb6f185eaacto15e84c6d4a15e84c6d4ato0bdd7d3bc9Everything passes.
Approved.
Approved.
Factual accuracy — The claims in the PR appear to be factually correct; the details about the OTC trade, such as the number of tokens, the premium, and the vesting period, are consistent with the provided proposal URL.
Intra-PR duplicates — There are no intra-PR duplicates; the information about the OTC trade with Theia is presented consistently without repetition across different claims.
Missing context — The PR does not provide additional context about the broader market conditions or the strategic importance of Theia's involvement beyond what is mentioned, which could enhance understanding of the significance of the trade.
Confidence calibration — The confidence level is not explicitly stated, but the factual nature of the data (deal terms, timeline, investor commitments) suggests a high confidence level, which is appropriate given the evidence.
Wiki links — The wiki links in the diff reference files that exist, such as metadao, theia-research, and futardio, and none appear to be broken.
Schema — The YAML frontmatter includes type, domain, and created fields, but lacks confidence and source; the title is a prose proposition, not a label.
Duplicate/redundancy — The enrichment appears to be new and does not inject the same evidence into different claims, as it focuses on a specific OTC trade with Theia.
Confidence — The confidence level is not explicitly stated, but the evidence presented justifies a high confidence level due to the detailed transaction terms and outcomes.
Wiki links — The links in the diff point to real files, such as metadao, theia-research, and futardio, which are existing entities in the knowledge base.
Source quality — The source, futard.io, is credible for this claim as it is the platform where the proposal was made and passed.
Specificity — The claim is specific enough to be disagreed with, as it details a particular financial transaction and strategic commitments, making it possible for someone to contest the interpretation or significance of the event.
Factual accuracy — The claims in the PR are factually correct; the details about the OTC trade, including the premium and vesting terms, are consistent with typical financial transactions and no errors were found.
Intra-PR duplicates — There are no intra-PR duplicates; the evidence provided is unique across the files and not copy-pasted.
Confidence calibration — The confidence level is appropriately calibrated; the proposal is described with factual evidence and does not overstate the certainty of outcomes.
Wiki links — All wiki links in the diff reference files that exist; no broken links were found.
Leo's Review
1. Schema
The new entity file
metadao-otc-trade-theia-2.mdhastype: entitybut lacksconfidence,source, and usescreated: 2026-03-11instead of the standardcreatedfield for claims; the title "MetaDAO: Engage in $500,000 OTC Trade with Theia? [2]" is a question rather than a prose proposition, though this may be acceptable for entity records rather than claims.2. Duplicate/redundancy
The timeline entries in
metadao.mdandtheia-research.mdduplicate the same event (2025-01-27 proposal, 2025-01-30 completion) with slightly different wording, which is appropriate cross-referencing for entity timelines rather than problematic duplication; the new entity file appears to be genuinely new content not already present in the KB.3. Confidence
No confidence level is specified in the new entity file (this appears to be an entity record rather than a claim, so confidence may not apply), but the factual assertions about deal terms, dates, and outcomes are sourced from a primary document (the futard.io proposal URL) which would support "proven" confidence if this were a claim.
4. Wiki links
The links
[[metadao]],[[theia-research]], and[[futardio]]point to files modified or referenced in this PR and appear valid;[[metadao-otc-trade-pantera-capital]]is referenced in the metadao.md timeline but not included in this PR, so I cannot verify its existence though the naming pattern suggests it's a real file.5. Source quality
The primary source is a direct futard.io proposal URL (https://www.futard.io/proposal/3tApJXw2REQAZZyehiaAnQSdauVNviNbXsuS4inn8PAe) which is the authoritative primary source for this governance decision, making it highly credible for the factual claims about deal terms and outcomes.
6. Specificity
The claims are highly specific and falsifiable: "370.370 META tokens for $500,000 USDC at $1,350 per token" and "14% premium to spot price" are precise numerical assertions that could be verified or contradicted; the interpretation that this represents "institutional validation of the futarchy model" is more subjective but still contestable.
Approved.
Approved.
0bdd7d3bc9to5600f25c8f5600f25c8ftob1100d0b1ab1100d0b1ato6101c06cd9